Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Chubb
QuintilesIMS
AstraZeneca
US Army
Healthtrust
McKesson
Boehringer Ingelheim
Deloitte

Generated: November 15, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR PYLORI-CHEK BREATH TEST

« Back to Dashboard

Clinical Trials for Pylori-chek Breath Test

Trial ID Title Status Sponsor Phase Summary
NCT00120315 Proton Pump Inhibitor Treatment Stop Completed Apotekerfonden af 1991 Phase 4 The purpose of this study is to determine how many chronic users of antisecretory medication can stop after a test for a bacteria associated with peptic ulcer disease. This is evaluated in a discontinuation trial.
NCT00120315 Proton Pump Inhibitor Treatment Stop Completed AstraZeneca Phase 4 The purpose of this study is to determine how many chronic users of antisecretory medication can stop after a test for a bacteria associated with peptic ulcer disease. This is evaluated in a discontinuation trial.
NCT00120315 Proton Pump Inhibitor Treatment Stop Completed Danish College of General Practitioners Phase 4 The purpose of this study is to determine how many chronic users of antisecretory medication can stop after a test for a bacteria associated with peptic ulcer disease. This is evaluated in a discontinuation trial.
NCT00120315 Proton Pump Inhibitor Treatment Stop Completed Research Unit of General Practice, Odense Phase 4 The purpose of this study is to determine how many chronic users of antisecretory medication can stop after a test for a bacteria associated with peptic ulcer disease. This is evaluated in a discontinuation trial.
NCT00120315 Proton Pump Inhibitor Treatment Stop Completed The Danish Medical Research Council Phase 4 The purpose of this study is to determine how many chronic users of antisecretory medication can stop after a test for a bacteria associated with peptic ulcer disease. This is evaluated in a discontinuation trial.
NCT00120315 Proton Pump Inhibitor Treatment Stop Completed University of Southern Denmark Phase 4 The purpose of this study is to determine how many chronic users of antisecretory medication can stop after a test for a bacteria associated with peptic ulcer disease. This is evaluated in a discontinuation trial.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Pylori-chek Breath Test

Condition Name

Condition Name for Pylori-chek Breath Test
Intervention Trials
Helicobacter Pylori Infection 33
Helicobacter Infections 6
Gastritis 5
Dyspepsia 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Pylori-chek Breath Test
Intervention Trials
Helicobacter Infections 47
Infection 30
Communicable Diseases 19
Gastritis 11
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Pylori-chek Breath Test

Trials by Country

Trials by Country for Pylori-chek Breath Test
Location Trials
Taiwan 23
United States 11
China 6
Japan 5
Italy 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Pylori-chek Breath Test
Location Trials
Texas 2
North Carolina 1
Nevada 1
Michigan 1
Maryland 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Pylori-chek Breath Test

Clinical Trial Phase

Clinical Trial Phase for Pylori-chek Breath Test
Clinical Trial Phase Trials
Phase 4 37
Phase 3 10
Phase 2/Phase 3 2
[disabled in preview] 21
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Pylori-chek Breath Test
Clinical Trial Phase Trials
Completed 33
Recruiting 18
Unknown status 9
[disabled in preview] 9
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Pylori-chek Breath Test

Sponsor Name

Sponsor Name for Pylori-chek Breath Test
Sponsor Trials
National Taiwan University Hospital 11
Mackay Memorial Hospital 4
Buddhist Tzu Chi General Hospital 4
[disabled in preview] 9
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Pylori-chek Breath Test
Sponsor Trials
Other 118
Industry 8
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Harvard Business School
McKesson
Merck
AstraZeneca
UBS
Boehringer Ingelheim
Citi
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.